Product Name | NebuSelect™ Recombinant Human CLEC10A, His-tag |
---|---|
Catalog Number | NBL-240739 |
Alias/Synonyms | CLEC10A; CD301; CLEC10A; CLECSF13; CLECSF14; HML; HML2; MGL |
Appearance | see COA |
Molecule Weight | Gln61-Ser316 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q8IUN9-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240739-100ug | 100ug | Inquire | Inquire | |
NBL-240739-1mg | 1mg | Inquire | Inquire | |
NBL-240739-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CLEC10A, His-tag
Catalog#:
NBL-240739
Description:
NebuSelect™ Recombinant Human CLEC10A, His-tag(Cat#NBL-240739) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln61-Ser316.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 29.7 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.
Target Name:
CLEC10A; CD301; CLEC10A; CLECSF13; CLECSF14; HML; HML2; MGL
Target Information:
CLEC10A, (C-type lectin domain family 10, member A), as the member of C-type lectin receptors (CLRs), plays a vital role in modulating innate immunity and adaptive immunity and has shown great potential as an immunotherapy target for cancers. However, there is no functional research of CLEC10A in prognostic risk, immunotherapy or any other treatment of lung adenocarcinoma (LUAD).
Amino Acid Sequence:
Gln61-Ser316
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.